Welcome to Medivizor!

You're browsing our sample library. Feel free to continue browsing. You can also sign up for free to receive medical information specific to your situation.

Posted by on May 8, 2021 in Colorectal cancer | 0 comments

In a nutshell

The aim of this study was to investigate the role of chemotherapy (CT) after surgery in patients with rectal cancer. The study suggests that CT after surgery could improve patient outcomes. 

Some background

Rectal cancer can be treated with surgery to remove the tumor. In general, patients are given CT before the surgery (neoadjuvant CT; NACT) to shrink the tumor and increase the chance that the surgeon can remove the entire tumor. Sometimes, patients can be given CT after surgery (adjuvant CT; ACT). ACT can kill any cancer cells that have been left behind or have moved to other parts of the body. However, ACT can also cause severe side effects.

It is not yet clear how beneficial ACT is for patients who have had NACT and full removal of the rectal tumor.

Methods & findings

This study evaluated data from 17,406 patients in 23 studies. The average follow-up time in these trials ranged from 35 – 120 months.

In patients that achieved full tumor removal after NACT, ACT was associated with a 32% higher chance of an improved overall survival. However, patients who had ACT had no significant increase in survival without the progression of the disease or without relapse.

The bottom line

The study concluded that ACT may improve the survival rate of patients with rectal cancer that have had complete removal of the tumor after NACT. 

The fine print

The study included data from a very wide range of trials. There were many differences in the types of ACT patients received. The study did not consider whether tumor size or type responded differently to ACT. Most of the studies analyzed were considered of low quality. Further studies are needed.

Published By :

International Journal of Colorectal Disease

Date :

Mar 27, 2021

Original Title :

Current evidence regarding the role of adjuvant chemotherapy in rectal cancer patients with pathologic complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis.

click here to get personalized updates